LDHA and neoplasm: Currently, gossypol (AT-101) and its derivatives FX-11, galloflavin, and N-hydroxy indole-based compounds have been shown to selectively and preferentially inhibit LDHA and suppress tumor progression (Ippolito et al., 2019).